Louis Moore Bacon's ABBV Position Overview
Louis Moore Bacon (via Moore Capital Management, Lp) currently holds 60.0K shares of AbbVie Inc. (ABBV) worth $13.89 M, representing 0.19% of the portfolio. First purchased in 2014-Q2, this long-term strategic position has been held for 46 quarters.
Based on 13F filings since 2013, Louis Moore Bacon has maintained a long-term strategic position in ABBV, representing a significant commitment to this investment thesis. Largest addition occurred in Q4 2021, adding 105.5K shares. Largest reduction occurred in Q3 2014, reducing 105.0K shares.
Analysis based on 13F filings available since 2013 Q2
Louis Moore Bacon's AbbVie (ABBV) Holding Value Over Time
Track share changes against reported price movement
Quarterly AbbVie (ABBV) Trades by Louis Moore Bacon
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2014 | +185,000 | New Buy | 185,000 | $56.44 |
| Q3 2014 | -105,000 | Reduce 56.76% | 80,000 | $57.76 |
| Q4 2014 | -49,956 | Reduce 62.44% | 30,044 | $65.44 |
| Q1 2015 | -30,044 | Sold Out | 30,044 | $0.00 |
| Q2 2015 | +25,000 | New Buy | 25,000 | $67.20 |
| Q3 2015 | -25,000 | Sold Out | 25,000 | $0.00 |
| Q4 2015 | +36,243 | New Buy | 36,243 | $59.24 |
| Q1 2016 | -36,243 | Sold Out | 36,243 | $0.00 |
| Q4 2021 | +141,739 | New Buy | 141,739 | $135.40 |
| Q1 2022 | -141,739 | Sold Out | 141,739 | $0.00 |
| Q3 2023 | +60,000 | New Buy | 60,000 | $149.06 |
| Q4 2023 | -60,000 | Sold Out | 60,000 | $0.00 |
| Q1 2025 | +45,000 | New Buy | 45,000 | $209.52 |
| Q2 2025 | +55,000 | Add 122.22% | 100,000 | $185.62 |
| Q3 2025 | -40,000 | Reduce 40.00% | 60,000 | $231.54 |
Louis Moore Bacon's AbbVie Investment FAQs
Louis Moore Bacon first purchased AbbVie Inc. (ABBV) in Q2 2014, acquiring 185,000 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Louis Moore Bacon has held AbbVie Inc. (ABBV) for 46 quarters since Q2 2014. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Louis Moore Bacon's largest addition to AbbVie Inc. (ABBV) was in Q2 2014, adding 185,000 shares worth $10.44 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Louis Moore Bacon's firm, Moore Capital Management, Lp, owns 60,000 shares of AbbVie Inc. (ABBV), valued at approximately $13.89 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, AbbVie Inc. (ABBV) represents approximately 0.19% of Louis Moore Bacon's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Louis Moore Bacon's peak holding in AbbVie Inc. (ABBV) was 185,000 shares, as reported at the end of Q2 2014. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.